Back
XTL Biopharmaceuticals Stock Price Chart
Free Access to "King of the Quants" Stock Rating System
[Claim Your 3 Free Grades Now]
Sell
30
XTLB
XTL Biopharmaceuticals
Last Price:
$1.66
Seasonality Move:
8.29%
7 Day Trial
ALL ACCESS PASS
$
7
Access "King of the Quants" Stock Rating System FREE!
[Claim Your 3 Free Grades Now]-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XTLB is experiencing selling pressure, which indicates risk of future bearish movement.
XTL Biopharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.85 | Sell |
| 20-day SMA: | 1.85 | Sell |
| 50-day SMA: | 1.83 | Sell |
| 200-day SMA: | 2.33 | Sell |
| 8-day EMA: | 1.82 | Sell |
| 20-day EMA: | 1.85 | Sell |
| 50-day EMA: | 1.89 | Sell |
| 200-day EMA: | 2.02 | Sell |
XTL Biopharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 40.68 | Sell |
| Chaikin Money Flow: | -9179 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.63 - 2.01) | Sell |
| Bollinger Bands (100): | (1.72 - 2.44) | Sell |
XTL Biopharmaceuticals Technical Analysis
| Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for XTL Biopharmaceuticals Stock
Is XTL Biopharmaceuticals Stock a Buy?
-
XTL Biopharmaceuticals share price is 1.66 while XTLB 8-day simple moving average is 1.85, which is a Sell signal.
-
The stock price of XTLB is 1.66 while XTL Biopharmaceuticals 20-day SMA is 1.85, which makes it a Sell.
-
XTL Biopharmaceuticals 50-day simple moving average is 1.83 while XTLB share price is 1.66, making it a Sell technically.
-
XTLB stock price is 1.66 and XTL Biopharmaceuticals 200-day simple moving average is 2.33, creating a Sell signal.
XTLB Technical Analysis vs Fundamental Analysis
Sell
30
XTL Biopharmaceuticals (XTLB)
is a Sell
Is XTL Biopharmaceuticals a Buy or a Sell?
-
XTL Biopharmaceuticals stock is rated a SellThe current XTL Biopharmaceuticals [XTLB] share price is $1.66. The Score for XTLB is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
XTL Biopharmaceuticals Stock Info
Market Cap:
14.6M
Price in USD:
1.66
Share Volume:
10K
XTL Biopharmaceuticals 52-Week Range
52-Week High:
4.99
52-Week Low:
0.77
Sell
30
XTL Biopharmaceuticals (XTLB)
is a Sell
XTL Biopharmaceuticals Share Price Forecast
-
What is the XTL Biopharmaceuticals stock price today?The XTL Biopharmaceuticals stock price is 1.66 USD today.
-
Will XTLB stock go up or go down?XTL Biopharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is XTL Biopharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, XTL Biopharmaceuticals is overvalued.
Is XTL Biopharmaceuticals Stock a Buy?
-
XTL Biopharmaceuticals share price is 1.66 while XTLB 8-day exponential moving average is 1.82, which is a Sell signal.
-
The stock price of XTLB is 1.66 while XTL Biopharmaceuticals 20-day EMA is 1.85, which makes it a Sell.
-
XTL Biopharmaceuticals 50-day exponential moving average is 1.89 while XTLB share price is 1.66, making it a Sell technically.
-
XTLB stock price is 1.66 and XTL Biopharmaceuticals 200-day simple moving average is 2.02, creating a Sell signal.
Technical Analysis of XTL Biopharmaceuticals
Should I short XTL Biopharmaceuticals stock?
-
XTLB Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting XTL Biopharmaceuticals is a Sell
-
XTL Biopharmaceuticals Relative Strength Index (RSI) is 40.68, which suggest XTL Biopharmaceuticals is oversold
-
The Bollinger Bands (25) for XTL Biopharmaceuticals is (1.63 - 2.01), which suggest XTL Biopharmaceuticals is a Sell
-
The Bollinger Bands (100) for XTL Biopharmaceuticals is (1.72 - 2.44), which suggest XTL Biopharmaceuticals is a Sell
* XTL Biopharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.